Women & Children

GSM after Breast Cancer

Improving genitourinary and sexual health for women with breast cancer: A nurse initiated plan of care

The side effects of adjuvant endocrine therapy for early breast cancer may contribute to noncompliance with treatment in up to 65% of patients, potentially increasing risk of recurrence and death. Genitourinary symptoms are one concern and can lead to pain, discomfort and impairment of sexual function (collectively termed as Genitourinary Syndrome of Menopause - GSM) which negatively impact on multiple domains of quality of life. These genitourinary side effects may be safely prevented or treated in many symptomatic women, but this requires recognition of symptoms and prompt intervention.

This research project proposes the development of a nurse initiated and delivered plan of care for GSM in women with breast cancer taking endocrine therapy to increase awareness and facilitate appropriate early intervention to manage symptoms. Breast care nurses are ideally placed to educate and inform patients about the GSM and that this could help improve health outcomes for women with breast cancer.

Project Team: Sousa M, Girgis A, Hickey M, Peate M, Durcinoska, I, Friedlander M.

^ Back To Top